Stockchase Opinions

Brian DawsonManulife FinancialMFC.TOHOLDJan 31, 2003

Fairly valued now. Long term looks good.
$34.99

Stock price when the opinion was issued

insurance
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

WATCH

Concern over earnings may explain drop today. Chart and 200-day MA still look intact. Very nice dividend. As with the rest of the market, have to be careful of overbought situations. Still sees double-digit growth. Watch the charts for entry points.

HOLD

In the doldrums following the financial crisis. Recently, taken the lead. The opportunity in this name has, perhaps, been fully realized.

He needs either a macro or company-specific hiccup to happen before putting new $$ to work in the market. At that time, you may want to take profits on this and deploy elsewhere. Watch out for headline contagion risk from private credit issues.

TOP PICK

He just bought it. Great execution, fine asset management and is a cash cow. Can increase the dividend again. Yields nearly 5% and trades under 10x PE. They will keep buying back stock. Also, they have little credit exposure, so no credit worries.

(Analysts’ price target is $56.11)
WEAK BUY

Viewed as less dependable as SLF and less exciting at Great West Life. MFC is well-capitalized with a decent PE though lifecos aren't great growers. Is reliable.

BUY

Doesn't know why this has come off. Maybe profit-taking after a good run. Is a reasonable, long-term holding. Is seeing growth in Asia. Life insurance is a stable business. Pays a good dividend yield.

BUY

It has pulled back to 10X this year's earnings and is quite a lot lower than the banks' ratio. It has shown success in Asia and in wealth management.

BUY
Sell MFC for GWO?

All the financials have come off slightly, especially in the insurance space. 

MFC has come down right to its 200-day MA, so you could argue it's got a bit more upside. High-quality name. Beta is double that of GWO, but no greater than the TSX itself. Scale is better than GWO. This one looks more attractive. He wouldn't switch, total return won't be that different. Yield is 4.3%.

GWO has a lower beta, so it hasn't moved as much as MFC. Good quality assets, very steady earnings growth. Yield is 4.3%.

HOLD

Bit of disappointment last quarter in US operations. Asia still has growth. Valuation in line with history at ~11x forward PE. Can still hold for its decent dividend yield.

COMMENT

He might own this, not sure. Recently, he predicted it would pull back to $45 which it appears to be doing. If you're a long-term holder for the 4.1% dividend, you're not in danger unless this falls below $45. If it bounces at $45, he would add more. But if you sold some shares now, that's a good idea.

WEAK BUY
Investor bought just this morning.

Well done, usually good to take advantage of short-term panics. 

This name has turned the corner. Good dividend yield. Higher rates let it get better returns on its bond portfolio. Good job growing its business. Reasonable valuation. Less exposed to worries of credit quality. Good long-term investment.

WEAK BUY
Reports after the bell today.

Lifecos traditionally trade at a discount to the Canadian banks. Why? It has to do with growth. Insurance is a mature market. This type of business doesn't deserve a 15x PE, especially the interest-rate risk you take on with an insurance company. To grow, MFC has a more Asian-centred business. In Asia it needs to partner with a local company, and the profit's a lot different than with a 100%-controlled subsidiary. 

Pays out significant portion of earnings in dividends, so it's more an income stock than a growth stock. Valuation is fair. If you want income, can't go wrong here. 

BUY

Funnily enough, life insurance companies actually do well in a lower interest rate environment. Plus, it has financial planning and investment divisions. A good non-bank alternative. Should continue to do well -- partly due to lower interest rates, partly due to stock market continuing to do well.

In his value/momentum strategy.

HOLD

Doesn't own any of the lifecos. This name struggled for quite a while, but then broke out on strategic repositioning by previous CEO. Changes have driven robust EPS growth. Businesses include Canada, US, wealth and asset management, and Asia (a faster secular grower). 

Now trades at premium to banks. Re-rating has largely played out. But if it can continue to grow earnings at high-single or low-double digits, plus dividend yield of ~3.something%, you have a pretty good line to a double-digit total shareholder return. He'd continue to hold.

HOLD
Has everything going for it, why not over $50?

Sometimes things happen in mysterious ways. Remember that the last price is set by the last buyer; the price you see on the screen is the price where 2 people most recently transacted. That doesn't tell you much about the future of the company or anything else.

Firstly, people have long memories. MFC hurt people so badly in the past, there are some people who just won't come back. His firm tries to be patient, seeing the future of companies when other investors are mad or unwilling. Also, stock has to digest its big move (most of which was last year). He's owned since $20, and is happy with where it is. Finally, most of the money in financials is flowing to banks.

Has performed extremely well. Doesn't disagree with the caller that stock could be $60. But something has to change to capture the attention of investors; for example, if PCLs for banks move up next year, $$ might rotate out and over to insurance.

HOLD

His preference is to own SLF and MFC in the sector. Likes their growth in Asian asset management.